Drug Survival of Omalizumab and Factors Associated With Discontinuation in Chronic Urticaria: A Meta-Analysis.

Altayf A, Kolkhir P, Alwefati M, Mendes-Bastos P, Jirafa R, Zuberbier T, Elhadi M

Open source

DOI
10.1001/jamadermatol.2026.2043
Published
2026 Sep 9
Container
JAMA dermatology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamadermatol.2026.2043,
  title = {Drug Survival of Omalizumab and Factors Associated With Discontinuation in Chronic Urticaria: A Meta-Analysis.},
  author = {Altayf A and Kolkhir P and Alwefati M and Mendes-Bastos P and Jirafa R and Zuberbier T and Elhadi M},
  year = {2026},
  journal = {JAMA dermatology},
  doi = {10.1001/jamadermatol.2026.2043},
  url = {https://doi.org/10.1001/jamadermatol.2026.2043}
}

RIS

TY  - JOUR
TI  - Drug Survival of Omalizumab and Factors Associated With Discontinuation in Chronic Urticaria: A Meta-Analysis.
AU  - Altayf A
AU  - Kolkhir P
AU  - Alwefati M
AU  - Mendes-Bastos P
AU  - Jirafa R
AU  - Zuberbier T
AU  - Elhadi M
PY  - 2026
JO  - JAMA dermatology
DO  - 10.1001/jamadermatol.2026.2043
UR  - https://doi.org/10.1001/jamadermatol.2026.2043
ER  - 

APA

A, A., P, K., M, A., P, M., R, J., T, Z., & M, E. (2026). Drug Survival of Omalizumab and Factors Associated With Discontinuation in Chronic Urticaria: A Meta-Analysis.. JAMA dermatology. https://doi.org/10.1001/jamadermatol.2026.2043

Source records